Bonjesta | Doxylamine Succinate And Pyridoxine Hydrochloride Tablet, Extended Release while Breastfeeding

What is Bonjesta | Doxylamine Succinate And Pyridoxine Hydrochloride Tablet, Extended Release ?

Can I use Bonjesta | Doxylamine Succinate And Pyridoxine Hydrochloride Tablet, Extended Release while breastfeeding?

Doxylamine succinate while Breastfeeding

CAS Number: 469-21-6

It is a first generation antihistamine drug which is related to ethanolamine, with sedative and anti-muscarinic effects. It has been used as hypnotic and for vomiting relief. At latest update, relevant published data on excretion into breast milk were not found. Pharmacokinetic characteristics would favour that it may be excreted into breast milk in significant amount. On a telephone survey, 10% of infants whose mothers were on several types of antihistamine medication have suffered of colicky pain and irritability that disappeared without treatment. For both treatment of mothers and infants would be safer the use of tested antihistamine medication without sedative effect, especially in prematures and infants younger than 1 month of age. Whenever used while breastfeeding, the use of the lower effective dose and for the shortest time as possible is recommended. Follow-up for somnolence and feeding troubles should be warranted. Bed-sharing is not recommended when the mother is on this medication.

Pyridoxine hydrochloride while Breastfeeding

CAS Number: 58-56-0

Concentration of vitamin B6 in the breast milk is directly related to the amount present in diet with the possibility of a high increment by an excessive consumption through the diet. Daily allowance of vitamin B6 ranges from 2 to 3 mg. A balanced and varied diet is enough without a need for extra supplementation with this vitamin. Vitamin B6 deficiency is extremely rare since it is widely distributed in many foods. In those cases where supplementation is required, it is recommended not to exceed 40 mg a-day. There are controversial data on the capacity of a high dose of Pyridoxine to inhibit the secretion of Prolactin and suppress the milk production. The American Academy of Pediatrics rates it as usually compatible with breastfeeding.

Doxylamine succinate while Breastfeeding

CAS Number: 469-21-6

Small occasional doses of doxylamine would not be expected to cause any adverse effects in breastfed infants. Larger doses or more prolonged use may cause drowsiness and other effects in the infant or decrease the milk supply, particularly in combination with a sympathomimetic such as pseudoephedrine or before lactation is well established.

What should I do if already breastfed my kid after using Bonjesta | Doxylamine Succinate And Pyridoxine Hydrochloride Tablet, Extended Release?

My doctor has prescribed me Bonjesta | Doxylamine Succinate And Pyridoxine Hydrochloride Tablet, Extended Release, what should I do?

If I am using Bonjesta | Doxylamine Succinate And Pyridoxine Hydrochloride Tablet, Extended Release, will my baby need extra monitoring?

Who can I talk to if I have questions about usage of Bonjesta | Doxylamine Succinate And Pyridoxine Hydrochloride Tablet, Extended Release in breastfeeding?